June 30, 2022
Life Sciences
  • The Biden administration announced that it will purchase 105 million doses of an updated Pfizer COVID-19 vaccine, pending Food and Drug Administration (FDA) approval. The updated vaccine is expected to target the omicron variant, with the goal of providing improved protection.  The $3.2 billion order is a major component of the administration’s fall vaccine campaign. The Biden administration is using money that it was forced to cut from other areas of its COVID-19 response after Congress did not act on the administration’s request for new funds.  (Press release here; Articles here, here, and here)